IP Library Granted Patent US 9,347,062
Granted Patent B2
US 9,347,062 · App. 14/156,227 · Granted May 24, 2016

Interfering RNA delivery system and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,347,062
App. No.
14/156,227
Granted
May 24, 2016
Kind
B2
Abstract

The invention provides a delivery system comprising a cell penetrating peptide, 10 histidines, and an interfering RNA molecule. The system can be used for delivering interfering RNA molecules into a cell in vivo or in vitro. Therapeutic uses for the delivery system are also provided.

Claims (19)

1. An interfering RNA delivery system comprising a molecular group consisting of an interfering RNA molecule linked to a YM3-10H peptide, wherein the YM3-10H peptide comprises an amino acid sequence selected from the group consisting of:

(SEQ ID NO: 2)

CHHHHHTHRLPRRRRRRHHHHHC and

(SEQ ID NO: 3)

HHHHHTHRLPRRRRRRHHHHHC.

2. The delivery system of claim 1 , wherein the interfering RNA molecule is linked to the YM3-10H peptide via a covalent bond.

3. The delivery system of claim 1 , wherein the interfering RNA molecule is a short interfering RNA (siRNA), micro RNA (miRNA), or short hairpin RNA (shRNA).

4. A pharmaceutical composition comprising the delivery system of claim 1 and a pharmaceutically acceptable carrier.

5. A method of delivering an interfering RNA molecule into a cell, comprising:

(a) attaching an interfering RNA molecule to a YM3-10H peptide, wherein the YM3-10H peptide comprises an amino acid sequence selected from the group consisting of:

CHHHHHTHRLPRRRRRRHHHHHC

(SEQ ID NO: 2)

and

HHHHHTHRLPRRRRRRHHHHHC,

(SEQ ID NO: 3)

thereby forming an interfering RNA delivery system; and

(b) administering the interfering RNA delivery system to the cell.

6. The method of claim 5 , wherein the interfering RNA molecule is linked to the YM3-10H peptide via a covalent bond.

7. The method of claim 5 , wherein the interfering RNA molecule is a siRNA, miRNA, or shRNA.

Assignments (2)
SECURITY INTEREST Recorded Aug 7, 2024
From: ARROWHEAD PHARMACEUTICALS, INC.
To: SIXTH STREETLENDING PARTNERS, AS THE ADMINISTRATIVE AGENT
Reel/Frame 068510/0363 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2015
From: ALCON RESEARCH, LTD.
To: ARROWHEAD RESEARCH CORPORATION
Reel/Frame 035653/0635 →